Company profile
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss
- CEO
- Mr. Graydon Bensler C.F.A.
- Headquarters
- Newport Beach, CA, United States
- Employees
- 32
- IPO date
- Nov 21, 2023
- Sector
- Healthcare
- Industry
- Biotechnology